2026年6月最新影响因子数据已更新，欢迎查询使用。如果您对期刊系统有任何需求或者问题，欢迎反馈给我们。
 |
体验更多LetPub AI科研工具 >> | |
| 近期推荐： | 热 全流程投稿协助套餐服务 | 热 SCI论文AI润色+人工QC服务 | 新 聚合物期刊JPM征稿｜IF持续上升 + APC折扣 | 热 Springer Nature特刊征稿 |
 |
| 基本信息 | 登录收藏 | |||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | Transplantation and Cellular Therapy （此期刊被最新的JCR期刊SCIE收录） LetPub评分 7.0
50人评分
我要评分
声誉 8.1 影响力 6.0 速度 7.0 | |||||||||||||||||||||||||||||||||||||||||
| 期刊ISSN | 2666-6375 | 安装APP，查看期刊最新消息
| ||||||||||||||||||||||||||||||||||||||||
| E-ISSN | 2666-6367 | |||||||||||||||||||||||||||||||||||||||||
| 2025-2026最新影响因子 （数据来源于搜索引擎） | 4.7 点击查看影响因子趋势图 | |||||||||||||||||||||||||||||||||||||||||
| 实时影响因子 | 截止2026年5月06日：4.12 | |||||||||||||||||||||||||||||||||||||||||
| 2025-2026自引率 | 10.6%点击查看自引率趋势图 | |||||||||||||||||||||||||||||||||||||||||
| 五年影响因子 | 4.3 | |||||||||||||||||||||||||||||||||||||||||
| JCI期刊引文指标 | 1.22 | |||||||||||||||||||||||||||||||||||||||||
| h-index | 暂无h-index数据 | |||||||||||||||||||||||||||||||||||||||||
| CiteScore （ 2026年6月最新版） |
| |||||||||||||||||||||||||||||||||||||||||
| 期刊简介 |
| |||||||||||||||||||||||||||||||||||||||||
| 期刊官方网站 | https://www.journals.elsevier.com/transplantation-and-cellular-therapy | |||||||||||||||||||||||||||||||||||||||||
期刊投稿格式模板 VIP专享 |
| |||||||||||||||||||||||||||||||||||||||||
| 期刊投稿网址 | ||||||||||||||||||||||||||||||||||||||||||
| 该期刊中国学者近期发文 - New | Exploration of In Vivo T-cell Depletion protocols in Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies Author: Chen, Hongru; Zhang, Yi; Fan, Yamin; Liu, Qianlin; Min, Wenyu; Xia, Linghui; Shi, Wei Journal: TRANSPLANTATION AND CELLULAR THERAPY. 2026; Vol. 32, Issue 4, pp. 412-427. DOI: 10.1016/j.jtct.2025.10.038 Prophylactic Versus Preemptive Donor Lymphocyte Infusion in Refractory/Relapsed AML Post-Allogeneic Transplant: A Retrospective Comparative Study Author: Wu, Ning; Yan, Chen-hua; Kong, Jun; Lv, Meng; Mo, Xiao-Dong; Sun, Yu-Qian; Cheng, Yi-Fei; Xu, Lan-Ping; Zhang, Xiao-Hui; Huang, Xiao-Jun; Wang, Yu Journal: TRANSPLANTATION AND CELLULAR THERAPY. 2026; Vol. 32, Issue 3, pp. 3020-. DOI: 10.1016/j.jtct.2025.10.029 Propensity Score-Matched Analysis Supports the Survival Benefits of Combination Chimeric Antigen Receptor T-Cell Therapy with Autologous Transplantation in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: Insights from a Real-World Study in China Author: Sheng, Kaiyu; You, Tao; Zhou, Jin; Wang, Yun; Wu, Depei; Huang, Haiwen Journal: TRANSPLANTATION AND CELLULAR THERAPY. 2026; Vol. 32, Issue 3, pp. 2880-. DOI: 10.1016/j.jtct.2025.11.001 One-Year Tear Proteomic Alterations with Topical Cyclosporine-A 0.1% Emulsion in Patients with Allogeneic Stem Cell Transplant Author: Liu, Chang; Wang, Xinyue; Yeo, Sharon Wan Jie; Lee, Isabelle Xin Yu; Linn, Yeh Ching; Ho, Aloysius; Than, Hein; Quek, Jeffrey Kim Siang; Hwang, William Ying Khee; Lim, Francesca Lorraine Wei Inng; Zhou, Lei; Liu, Yu-Chi; Tong, Louis; Lim, Li Journal: TRANSPLANTATION AND CELLULAR THERAPY. 2026; Vol. 32, Issue 3, pp. 3040-. DOI: 10.1016/j.jtct.2025.11.017 | |||||||||||||||||||||||||||||||||||||||||
| 期刊语言要求 | Language Please write your text in good English (American or British usage is accepted, but not a mixture of these). Authors who feel their English language manuscript may require editing to eliminate possible grammatical or spelling errors and to conform to correct scientific English may wish to use the English Language Editing service. 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件，不仅能满足Transplantation and Cellular Therapy的语言要求，还能让Transplantation and Cellular Therapy编辑和审稿人得到更好的审稿体验，让稿件最大限度地被Transplantation and Cellular Therapy编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）帮助作者准备稿件，已助力全球15万+作者顺利发表论文。部分发表范例可查看：服务好评 论文致谢 。 提交文稿 | |||||||||||||||||||||||||||||||||||||||||
| 是否OA开放访问 | Yes | |||||||||||||||||||||||||||||||||||||||||
| 通讯方式 | ||||||||||||||||||||||||||||||||||||||||||
| 出版商 | Elsevier | |||||||||||||||||||||||||||||||||||||||||
| 涉及的研究方向 | Medicine-Hematology | |||||||||||||||||||||||||||||||||||||||||
| 出版国家或地区 | ||||||||||||||||||||||||||||||||||||||||||
| 出版语言 | ||||||||||||||||||||||||||||||||||||||||||
| 出版周期 | ||||||||||||||||||||||||||||||||||||||||||
| 出版年份 | 0 | |||||||||||||||||||||||||||||||||||||||||
| 年文章数 | 217点击查看年文章数趋势图 | |||||||||||||||||||||||||||||||||||||||||
| Gold OA文章占比 | 28.92% | |||||||||||||||||||||||||||||||||||||||||
| 研究类文章占比： 文章 ÷（文章 + 综述） | 89.86% | |||||||||||||||||||||||||||||||||||||||||
| WOS期刊JCR分区 （ 2025-2026年最新版） | WOS分区等级：1区
| |||||||||||||||||||||||||||||||||||||||||
| 期刊分区表预警名单 | 2026年03月发布的新锐学术版：不在预警名单中 2025年03月发布的2025版：不在预警名单中 2024年02月发布的2024版：不在预警名单中 2023年01月发布的2023版：不在预警名单中 2021年12月发布的2021版：不在预警名单中 2020年12月发布的2020版：不在预警名单中 | |||||||||||||||||||||||||||||||||||||||||
  | ||||||||||||||||||||||||||||||||||||||||||
| 《新锐期刊分区表》 （ 2026年3月发布） | 点击查看期刊分区表趋势图
| |||||||||||||||||||||||||||||||||||||||||
| 期刊分区表 （ 2025年3月升级版） |
| |||||||||||||||||||||||||||||||||||||||||
| 期刊分区表 （ 2023年12月旧的升级版） |
| |||||||||||||||||||||||||||||||||||||||||
| SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月，原SCI撤销合并入SCIE，统称SCIE) Scopus (CiteScore) | |||||||||||||||||||||||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=2666-6375%5BISSN%5D | |||||||||||||||||||||||||||||||||||||||||
| 平均审稿速度 | 网友分享经验： | |||||||||||||||||||||||||||||||||||||||||
| 平均录用比例 | 网友分享经验： | |||||||||||||||||||||||||||||||||||||||||
| LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍，平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）后论文在Transplantation and Cellular Therapy顺利发表。
快看看作者怎么说吧：服务好评 论文致谢 。 提交文稿 | |||||||||||||||||||||||||||||||||||||||||
| 期刊常用信息链接 |
| |||||||||||||||||||||||||||||||||||||||||
|
| |
| 中国学者近期发表的论文 | |
| 1. | Exploration of In Vivo T-cell Depletion protocols in Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies Author: Chen, Hongru; Zhang, Yi; Fan, Yamin; Liu, Qianlin; Min, Wenyu; Xia, Linghui; Shi, Wei Journal: TRANSPLANTATION AND CELLULAR THERAPY. 2026; Vol. 32, Issue 4, pp. 412-427. DOI: 10.1016/j.jtct.2025.10.038 PubMed DOI |
| 2. | Prophylactic Versus Preemptive Donor Lymphocyte Infusion in Refractory/Relapsed AML Post-Allogeneic Transplant: A Retrospective Comparative Study Author: Wu, Ning; Yan, Chen-hua; Kong, Jun; Lv, Meng; Mo, Xiao-Dong; Sun, Yu-Qian; Cheng, Yi-Fei; Xu, Lan-Ping; Zhang, Xiao-Hui; Huang, Xiao-Jun; Wang, Yu Journal: TRANSPLANTATION AND CELLULAR THERAPY. 2026; Vol. 32, Issue 3, pp. 3020-. DOI: 10.1016/j.jtct.2025.10.029 PubMed DOI |
| 3. | Propensity Score-Matched Analysis Supports the Survival Benefits of Combination Chimeric Antigen Receptor T-Cell Therapy with Autologous Transplantation in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: Insights from a Real-World Study in China Author: Sheng, Kaiyu; You, Tao; Zhou, Jin; Wang, Yun; Wu, Depei; Huang, Haiwen Journal: TRANSPLANTATION AND CELLULAR THERAPY. 2026; Vol. 32, Issue 3, pp. 2880-. DOI: 10.1016/j.jtct.2025.11.001 PubMed DOI |
| 4. | One-Year Tear Proteomic Alterations with Topical Cyclosporine-A 0.1% Emulsion in Patients with Allogeneic Stem Cell Transplant Author: Liu, Chang; Wang, Xinyue; Yeo, Sharon Wan Jie; Lee, Isabelle Xin Yu; Linn, Yeh Ching; Ho, Aloysius; Than, Hein; Quek, Jeffrey Kim Siang; Hwang, William Ying Khee; Lim, Francesca Lorraine Wei Inng; Zhou, Lei; Liu, Yu-Chi; Tong, Louis; Lim, Li Journal: TRANSPLANTATION AND CELLULAR THERAPY. 2026; Vol. 32, Issue 3, pp. 3040-. DOI: 10.1016/j.jtct.2025.11.017 PubMed DOI |
| 5. | Impact of HLA Alloimmunization on Availability of HLA Matched and Mismatched Unrelated Allogeneic Hematopoietic Cell Donors for Transplantation Disproportionately Impacts Female Patients Author: Shaffer, Brian C.; Blouin, Amanda G.; Rapoport, Candice; Wells, Deborah S.; Chinapen, Stephanie; Perales, Miguel-Angel; Devine, Steven M.; Auletta, Jeffery J.; Stefanski, Heather E.; Spellman, Stephen R.; Maiers, Martin Journal: TRANSPLANTATION AND CELLULAR THERAPY. 2026; Vol. 32, Issue 2, pp. -. DOI: |
| 6. | Bleximenib or Placebo in Combination with Standard Induction and Consolidation Therapy Followed By Maintenance for the Treatment of Patients with Newly Diagnosed KMT2A-Rearranged or NPM1-Mutant Acute Myeloid Leukemia Eligible for Intensive Chemotherapy: A Double-Blind phase 3 Study (HOVON 181 AML / AMLSG 37-25) Author: Raaijmakers, Marc; Dohner, Hartmut; Breems, Dimitri; Byrd, John C.; Dohner, Konstanze; Esteve, Jordi; Gjertsen, Bjorn Tore; Gradowska, Patrycja; Huls, Gerwin; Kaare, Ain; Kim, Hee-Je; Kiyoi, Hitoshi; Kontro, Mika; Krawczyk, Janusz; Lazarevic, Vladimir; Lenartova, Andrea; Mims, Alice; Refos, Jeannine M.; Rollig, Christoph; Schrade, Anika; Sikorska, Karolina; Theocharides, Alexandre; Valk, Peter; Venditti, Adriano; Wang, Jianxiang; Wei, Andrew H.; Wierzbowska, Agnieszka; Andrius-Zucenka; Ferrante, Lucille; Guttke, Christina; Langlois, Angelique; Loefgren, Christina; Packman, Kathryn; Shastri, Prathap Nagaraja; Schuier, Natasha; Thayu, Meena; Trancucci, Danielle; Lowenberg, Bob; Bullinger, Lars Journal: TRANSPLANTATION AND CELLULAR THERAPY. 2026; Vol. 32, Issue 2, pp. -. DOI: |
| 7. | Camelot-2: A phase 3 Randomized, Double-Blind, Placebo-Controlled, Study of Bleximenib, Venetoclax and Azacitidine for the Treatment of Participants with Newly Diagnosed Acute Myeloid Leukemia Harboring KMT2A rearrangements or NPM1 mutations, Who Are Ineligible for Intensive Chemotherapy Author: Jabbour, Elias; Sallman, David A.; Briseno-Toomey, Deborah; Guttke, Christina; Huang, Xiaojun; Dillon, Richard; Ferrante, Lucille; Ikesoe, Takayuki; Langlois, Angelique; Loefgren, Christina; Nachmias, Boaz; Nelson, Ayelet; Packman, Kathryn; Shastri, Prathap Nagaraja; Recher, Christian; Roboz, Gail J.; Schuier, Natasha; Thayu, Meena; Trancucci, Danielle; Zuppa, Athena; Ro, Christoph; Wei, Andrew H Journal: TRANSPLANTATION AND CELLULAR THERAPY. 2026; Vol. 32, Issue 2, pp. -. DOI: |
| 8. | Long-Term Progression-Free Survival Benefit with Ciltacabtagene Autoleucel in Standard-Risk relapsed/refractory Multiple Myeloma Author: Costa, Luciano J.; Oriol, Albert; Dytfeld, Dominik; Manier, Salomon; Voorhees, Peter M.; Lin, Yi; Htut, Myo; Roeloffzen, Wilfried; Ho, Phoebe Joy; Shah, Urvi A.; Zhao, Man; Li, Quanlin; Balogh, Agnes; Li, Katherine; Slaughter, Ana; Benachour, Nina; Lonardi, Carolina; Ghosh, Arnab; Sun, Huabin; Lendvai, Nikoletta; Lengil, Tamar; Patel, Nitin; Koneru, Mythili; Florendo, Erika; Filho, Octavio Costa; Mahajan, Vrinda; Rodriguez-Otero, Paula; Strouse, Christopher; Stewart, A. Keith; Sidana, Surbhi Journal: TRANSPLANTATION AND CELLULAR THERAPY. 2026; Vol. 32, Issue 2, pp. -. DOI: |
| 9. | Pre-Transplant MRD Negativity Predicts Favorable Outcomes of CAR-T Therapy for Pediatirc Relapsed and Refractory Acute Lymphoblastic Leukemia Followed By TCR Ab-Depleted Haplo-HSCT Author: Liu, Huaying; Jing, Zhihao; Simeng, Yuelin; Wang, Chunfu; Lv, Tang; Li, He Journal: TRANSPLANTATION AND CELLULAR THERAPY. 2026; Vol. 32, Issue 2, pp. S32-S32. DOI: |
| 10. | Landmark Long-Term Remission Achieved with ICG318, a BCMA-CD19 Armored Compound CART-cell Therapy, in Refractory Systemic Lupus Erythematosus/Lupus Nephritis with Follow-up Approaching 6 Years Author: Hong, Ming; Wang, Mingxia; Zeng, Ronghao; Ding, Ling; He, Shanzhi; Lan, Ting; DeStefano, Vincent M.; Wada, Masayuki; Pinz, Kevin; Chow, Jennifer E.; Choi, Byeong Hyeok; Hagag, Nabil; Wang, Min; Ma, Yu; Luo, Jing; Liang, Yingwen; Lu, Ziji; Zhang, Wenli; Ding, Shihao; Ma, Yupo; Wang, Weijia Journal: TRANSPLANTATION AND CELLULAR THERAPY. 2026; Vol. 32, Issue 2, pp. S38-S38. DOI: |
|
|
  | ||||||||||||||||
|
投稿状态统计： 我要评分： | ||||||||||||||||
| 投稿前担心稿件结构或语言不够规范？试试稿件自查工具，一键检测 >> | ||||||||||||||||
|
||||||||||||||||
同领域作者分享投稿经验：共0条 |
||||||||||||||||
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2026 中国: LetPub上海 网站备案号：沪ICP备10217908号-1 
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
增值电信业务经营许可证：沪B2-20211595 网络文化经营许可证：沪网文[2023]2004-152号
礼翰商务信息咨询（上海）有限公司 办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室
安全保密
投稿信 (Cover Letter) 模板
